Case Report: pharmaceutical care in a case of complicated urinary tract infection combined with disseminated Nocardia brasiliensis infection - Report - MDSpire

Case Report: pharmaceutical care in a case of complicated urinary tract infection combined with disseminated Nocardia brasiliensis infection

  • By

  • Houjun Pang

  • Chuan Pi

  • Pengyu Shen

  • Ziru Tang

  • Erhao Bao

  • Xing Luo

  • Qixiong Zhang

  • June 11, 2026

  • 0 min

Share

Clinical Report: Pharmaceutical Management in Urinary Tract Infection Complicated by Nocardia

Overview

This report details the management of a 67-year-old male patient with a complicated urinary tract infection (cUTI) due to Enterococcus faecalis, complicated by disseminated Nocardia brasiliensis infection.

Background

The increasing prevalence of multidrug-resistant pathogens poses significant challenges in managing infections, particularly those that are disseminated.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • The patient was diagnosed with disseminated Nocardia brasiliensis infection and Enterococcus faecalis cUTI.
  • Initial treatment with meropenem was ineffective, prompting a switch to a regimen including TMP-SMX and linezolid.
  • Severe thrombocytopenia occurred during treatment, necessitating a change to amoxicillin/clavulanate potassium.
  • Rapid pathogen identification using metagenomic next-generation sequencing (mNGS) was critical for guiding therapy.
  • Intensive pharmaceutical monitoring allowed for timely adjustments to the treatment regimen.

Clinical Implications

This case underscores the necessity of rapid diagnostic tools and tailored antimicrobial regimens in managing complex infections. Continuous monitoring for adverse reactions and treatment efficacy is essential for optimizing patient care.

Conclusion

Effective management of complicated infections requires a combination of precise diagnostics and proactive pharmaceutical care. This case illustrates the critical role of individualized treatment strategies in achieving favorable patient outcomes.

Related Resources & Content

  1. Infection, Dosing Strategies for Trimethoprim-Sulfamethoxazole and Clinical Outcomes in Pulmonary Nocardiosis, 2024 -- https://link.springer.com/article/10.1007/s15010-024-02323-9
  2. Open Forum Infectious Diseases, Factors Influencing Disseminated Nocardiosis and Associated Outcomes in Different Host Risk Categories, 2023 -- https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofag008/8422466
  3. Infection, Comparative Analysis of Short and Standard Antibiotic Treatment Durations for Nocardiosis: A Retrospective Cohort Study Across Multiple Centers, 2024 -- https://link.springer.com/article/10.1007/s15010-024-02445-0
  4. Frontiers in Medicine, Case Report: Basal ganglia brain abscess caused by Nocardia farcinica, 2026 -- https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1798434/full
  5. IDSA releases new guidelines for management and treatment of complicated urinary tract infections, 2025 -- https://www.idsociety.org/~/link/ccdff7155ad24856848cd4365b7c4dd3.aspx
  6. Infection — Dosing Strategies for Trimethoprim-Sulfamethoxazole and Clinical Outcomes in Pulmonary Nocardiosis
  7. Open Forum Infectious Diseases — Factors Influencing Disseminated Nocardiosis and Associated Outcomes in Different Host Risk Categories
  8. Infection — Comparative Analysis of Short and Standard Antibiotic Treatment Durations for Nocardiosis: A Retrospective Cohort Study Across Multiple Centers
  9. Frontiers in Medicine — Case Report: Basal ganglia brain abscess caused by Nocardia farcinica
  10. IDSA releases new guidelines for management and treatment of complicated urinary tract infections
  11. https://academic.oup.com/cid/article/80/4/e53/8123297
  12. Population-based microbiological characterization of Nocardia strains causing invasive infections during a multiyear period in a large Canadian healthcare region | Microbiology Spectrum

Original Source(s)

Related Content